Repare Therapeutics Inc. (RPTX)
2.650
+0.020 (0.76%)
Inactive · Last trade price on Jan 27, 2026
Repare Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | 11.87 | 53.48 | 51.13 | 131.83 | 7.6 | 0.14 |
Revenue Growth | -82.16% | 4.58% | -61.21% | 1634.61% | 5529.63% | - |
Gross Profit Gross Profit Growth | 47.88 | 40.1 | 37.89 | 15.11 | -80.25 | -38.64 |
Operating Income Operating Income Growth | -79.21 | -92.14 | -116.22 | -19.8 | -108.66 | -54.3 |
Net Income Net Income Growth | -72.2 | -84.69 | -93.8 | -29.05 | -106.91 | -53.42 |
Earnings Per Share EPS Growth | -1.69 | -2.00 | -2.23 | -0.69 | -2.83 | -2.66 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
United States United States Growth | 26.1 | 15.2 | 7.6 | 0.14 |
Switzerland Switzerland Growth | 14.5 | 116.6 | - | - |
Japan Japan Growth | 10.5 | - | - | - |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Investments Cash & Investments Growth | 112.6 | 152.79 | 223.63 | 343.94 | 341.87 | 333.71 |
Total Debt Total Debt Growth | 0.34 | 1.93 | 3.41 | 5.43 | 7.31 | 4.01 |
Net Cash (Debt) Net Cash Growth | 112.26 | 150.86 | 220.22 | 338.51 | 334.55 | 329.71 |
Net Cash Growth | -36.53% | -31.50% | -34.95% | 1.18% | 1.47% | 251.75% |
Net Cash Per Share Net Cash Per Share Growth | 2.63 | 3.56 | 5.23 | 8.07 | 8.85 | 16.45 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | -70.15 | -76.45 | -127.16 | 0.32 | -85.8 | -6.08 |
Capital Expenditures CapEx Growth | - | - | -1.94 | -0.6 | -1.69 | -2.24 |
Free Cash Flow Free Cash Flow Growth | -70.15 | -76.45 | -129.1 | -0.28 | -87.49 | -8.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Gross Margin | 403.39% | 74.98% | 74.11% | 11.46% | - | - |
Operating Margin | -667.31% | -172.31% | -227.30% | -15.02% | -1429.74% | -40223.70% |
Pretax Margin | -601.83% | -155.67% | -201.79% | -10.54% | -1428.76% | -40549.63% |
Profit Margin | -608.26% | -158.37% | -183.44% | -22.03% | -1406.68% | -39568.15% |
FCF Margin | -590.97% | -142.95% | -252.47% | -0.21% | -1151.13% | -6163.70% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PS Ratio | 9.54 | 1.04 | 6.02 | 4.68 | 115.82 | 9341.04 |